Poging GOUD - Vrij
Can You Beat Cellulite?
PRIME Magazine
|Oct - Nov 2017
It’s a problem most women face: cellulite! Sadly, it is much more common in women than in men because of differences in the way fat, muscle, and connective tissue are distributed in men’s and women’s skin. But not all cellulite is created equal. Who knew? Turns out there are 4 basic types – and most of us have one of them.
-
TYPE 1: Loose Skin Cellulite
With age, as collagen and elastin fibers in the tissues weaken, there is increased sliding of the skin over the muscles and tissues, causing dimpling in the skin surface. While looking in a mirror, take two fingers and pinch the skin underneath your eye or on the top of your hand. When you release it, if the skin is sluggish to snap back, that’s a sign you probably have loose skin cellulite.
How to tackle it: Look for lotions that have 3 main ingredients that help firm the skin: red algae, peptides and vitamin A. They can help bring back some of the elasticity that you may have lost over time. Apply the lotion twice per day, and be sure to apply a dime-sized amount per area, and massage in thoroughly.
TYPE 2: Poor Circulation Cellulite
This is when the fat beneath the skin is pushed against the surrounding connective tissue, and the excess fat amassed is the superficial layer of tissue bulges between bands of connective tissue. Two clues that signal you might have it are cold hands and feet, and sparse hair on your legs.
How to tackle it: Experts suggests using a dry brush to scrub the area in a circular motion for about 10 minutes on each leg. Doing this every day will wear down the fibres that are buckling and will smooth them out.
TYPE 3: Lack of Exercise Cellulite
Skipping your workouts can cause an increase in fatty tissue, making cellulite more noticeable. This is very common in people who have had recent weight gain or weight loss.
Dit verhaal komt uit de Oct - Nov 2017-editie van PRIME Magazine.
Abonneer u op Magzter GOLD voor toegang tot duizenden zorgvuldig samengestelde premiumverhalen en meer dan 9000 tijdschriften en kranten.
Bent u al abonnee? Aanmelden
MEER VERHALEN VAN PRIME Magazine
PRIME Singapore
Living Large
The Illusion of Space in Small Homes
9 mins
February - March 2026
PRIME Singapore
Fend Off the Flames
Fire Safety Knowledge That Can Save Lives
7 mins
February - March 2026
PRIME Singapore
The World in Numbers
How Data Analytics Shapes Modern Decision-Making
14 mins
February - March 2026
PRIME Singapore
Thunder Struck
Chris Hemsworth: From God of Thunder to Hollywood Deity
29 mins
February - March 2026
PRIME Singapore
Ingesting Inflammation
Why Everyone is Talking About Anti-Inflammatory Diets
12 mins
February - March 2026
PRIME Singapore
Inked Later
Why More People Are Getting Tattoos After 40
7 mins
February - March 2026
PRIME Singapore
STUDY CONFIRMS ONE MONTH OF NO ALCOHOL MAKES REAL DIFFERENCE TO HEALTH
In 2013, Alcohol Change UK started the “Dry January” campaign, where people could commit to abstaining from drinking alcohol for the entire month.
2 mins
February - March 2026
PRIME Singapore
CERTAIN CHANGES IN DRIVING PATTERNS MAY POINT TO COGNITIVE DECLINE, DEMENTIA
Individuals with cognitive impairment are at a two-to five-fold increased risk of being involved in motor accidents, highlighting the deterioration of driving skills with a decline in cognitive function. A recent study published in Neurology suggests that changes in daily driving patterns recorded using a vehicle datalogger could reliably distinguish individuals with mild cognitive impairment (MCI) from those with normal cognition. The study’s findings suggest that data collected by vehicle data loggers could potentially be used in the early identification of individuals at risk of a motor crash or those with cognitive impairment, prior to in-person cognitive assessments or brain imaging scans. Driving data patterns could also serve as a tool to assess the effectiveness of interventions for treating cognitive impairment.
2 mins
February - March 2026
PRIME Singapore
LIFT ME UP
Volformer: The Rejuvenation Protocol Combining Precision Ultrasound and Volumetric RF
4 mins
February - March 2026
PRIME Singapore
TARGETING IDO1 FOR CANCER: NOVEL DEGRADERS SHOW PROMISE IN PRECLINICAL STUDIES
Cancer cells employ a variety of strategies to evade the immune system, and modern immunotherapies aim precisely at these escape mechanisms. However, such therapies are not always successful. A research team from the Max Planck Institute for Molecular Physiology in Dortmund and the AITHYRA Institute in Vienna has now developed a new class of compounds that specifically target and destroy the enzyme IDO1 – a key molecular switch that tumours use to suppress immune responses. They were also able to show that iDegs (IDO1 degraders) inhibit tumour growth in mice with SKOV-3 tumours, thereby prolonging survival time. This approach could markedly enhance the efficacy of existing immunotherapies and open new avenues in the fight against cancer. The new research was published in the journal Nature.
3 mins
February - March 2026
Translate
Change font size

